脂肪性肝病,Fatty liver disease
1)Fatty liver disease脂肪性肝病
1.Fatty liver disease and primary liver cancer;脂肪性肝病与原发性肝癌
2.Objective To study the role of apoptosis of rat liver cell in the pathologic mechanism of fatty liver disease (FLD).目的研究细胞凋亡在实验性脂肪性肝病大鼠病理机制中的作用。
3.Background:The prevalence rate of fatty liver disease(FLD) is increasing today, and it s prevention and therapy also receive more attention.背景：近年来脂肪性肝病(fatty liver disease，FLD)患病率呈逐年增高趋势，其防治也逐渐受到重视，但FLD发病机制复杂，迄今仍不明确。
英文短句/例句
1.A Study on Fatty Acid Composition in the Liver of Rats with Non-alcoholic Fatty Liver Disease;大鼠非酒精性脂肪性肝病肝脏脂肪酸谱的研究
2.The Characters of Liver Function Disorder in Nonalcoholic Fatty Liver Disease;非酒精性脂肪性肝病肝功能改变特点
3.Progresses about Adipokines and Nonalcoholic Fatty Liver Disease脂肪因子与非酒精性脂肪性肝病研究进展
4.Roles of adipocytokines in the pathogenesis of non-alcoholic fatty liver disease脂肪细胞因子在非酒精性脂肪性肝病中的作用
5.Unity of Opposites of Alcoholic Fatty Liver Disease and Non-alcoholic Fatty Liver Disease;酒精性脂肪性肝病与非酒精性脂肪性肝病的对立统一
6.Pathogenesis of nonalcoholic fatty liver disease:a perspective from metabolism非酒精性脂肪性肝病的代谢发病机制
7.Basic Application Research on Nonalcoholic Fatty Liver Disease非酒精性脂肪性肝病的应用基础研究
8.The Fatty Liver Disease and Metabolic Syndrome: A Cross-sectional Study;脂肪性肝病与代谢综合征的现况调查
9.Application of lipid-lowering drugs in prevention and treatment of NAFLD.降脂药防治非酒精性脂肪性肝病临床价值
10.Identification of Gene Expression Patterns in a Rat Model of Nonalcoholic Fatty Liver Disease;非酒精性脂肪性肝病大鼠肝脏基因表达谱分析
11.Effect of Shugan Granules on Perosisome Proliferator-activated Receptor Gamma mRNA in Non-alcoholic Fatty Liver Disease in Rats舒肝颗粒对非酒精性脂肪性肝病PPAR-γmRNA的影响
12.Expression of SSeCKS in nonalcoholic fatty liver of rats非酒精性脂肪性肝病大鼠肝脏SSeCKS的表达
13.Application of hepatoprotectors in prevention and treatment of NAFLD.保肝药物防治非酒精性脂肪性肝病临床价值
14.Changes of NO and iNOS Levels in Liver Tissues in Rats with Nonalcoholic Fatty Liver Disease非酒精性脂肪性肝病大鼠肝组织NO和iNOS的变化
15.Study on the Pathogenesis of Experimental Nonalcoholic Fatty Liver Disease;实验性非酒精性脂肪性肝病发病机制的研究
16.The Study of Expression and Significance of Sterol Regulatory Element Binding Proteins in the Liver of Patients with Fatty Liver Disease;脂肪性肝病患者肝组织SREBPs的表达及意义的研究
17.The Pathogenesis of Cytochrome P450 2E1 in Fatty Liver Disease;细胞色素P450 2E1在脂肪性肝病中的致病作用
18.The Efficacy and Mechanism Study of Qinggantiaozhi Decoction Preventing and Treating Nonalcoholic Fatty Liver Disease;清肝调脂饮防治非酒精性脂肪性肝病的疗效及机制研究
相关短句/例句
fatty liver脂肪性肝病
1.Analysis of risk factors for nonalcoholicfatty liver disease in children with simple obesity肥胖儿童非酒精性脂肪性肝病发病的相关危险因素分析
3)diabetic fatty liver糖尿病性脂肪肝
1.Objective: To explore the relation between insulin resistance anddiabetic fatty liver and to study the prophylaxis and treatment ofdiabetic fatty liver with Tang Gan Kang (TGK).目的：探讨糖尿病性脂肪肝与胰岛素抵抗的关系以及中药糖肝康对糖尿病性脂肪肝胰岛素抵抗的防治作用。
4)Nonalcoholic fatty liver disease非乙醇性脂肪性肝病
1.Nonalcoholic fatty liver disease(NAFLD) is a kind of chronic liver disease,whose spectrum of the disease includes simple hepar adiposum,steatohepatitis(NASH),hepatic fibrosis,and cirrhosis.非乙醇性脂肪性肝病(NAFLD)是一种常见的慢性肝病,其疾病谱包括单纯性脂肪肝、非乙醇性脂肪性肝炎(NASH)、肝纤维化及肝硬化。
2.Nonalcoholic fatty liver disease(NAFLD)is now recognized as the most common liver disease which does harm to people s health in the world.非乙醇性脂肪性肝病已成为一种常见的危害人类健康的疾病,早期可以仅出现肝细胞脂肪变性,进一步可发展为脂肪性肝炎、肝纤维化、肝硬化等终末期病变。
5)Nonalcoholic fatty liver disease非酒精性脂肪性肝病
1.Analysis of Perilipin and ADRP changes in the nonalcoholic fatty liver disease;非酒精性脂肪性肝病发生中Perilipin和ADRP表达变化实验研究
2.Secretory status of pancreas and pathogenesis of insulin resistance in rat with nonalcoholic fatty liver disease;非酒精性脂肪性肝病大鼠胰腺分泌状态及胰岛素抵抗观察
3.Nonalcoholic Fatty Liver Disease with Increased Incidence of Metabolic Disorders;非酒精性脂肪性肝病患者代谢紊乱发病率增高
6)Nonalcoholic fatty liver diseases非酒精性脂肪性肝病
1.Therapeutic effect of weight loss combining bicyclol on primary nonalcoholic fatty liver diseases;减轻体重联合百塞诺治疗非酒精性脂肪性肝病疗效分析
2.Objetive:To investigate the efficacy and safety of Jianpi Bushen herb in the treatment of nonalcoholic fatty liver diseases(NAFLD).目的:研究健脾补肾中药治疗非酒精性脂肪性肝病的疗效和安全性。
延伸阅读
酒精性肝病酒精性肝病alcoholic liver disease由酒精中毒引起肝脏疾病，主要有酒精性脂肪肝、酒精性肝炎及肝硬化。酒精性脂肪肝是因乙醇在肝内代谢为乙醛及乙酸时，辅酶Ⅰ转变为还原辅酶Ⅰ增加，抑制三羧酸循环，肝内脂肪酸合成增多而致脂肪肝。酒精性肝炎为肝细胞肿胀，线粒体变形，胞质中出现乙醇透明小体，肝细胞变性，周围纤维化。严重者可出现小结节性肝硬化。临床常表现为肝肿大，常与病变程度相关，轻者无症状，重者可有肝炎表现。肝硬化者除有一般肝硬化表现外，还有慢性酒精中毒引起的掌挛缩和脑病等表现。无特异性治疗，以高热量平衡饮食、护肝、补充维生素等；肝硬化则同其他肝硬化一样处理。
